regardless Archives - tgiHealthCareerp

FDA Approves Opdivo (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma Regardless of PD-L1 Expression Status

04/18/2021 (nivolumab), Adenocarcinoma, advanced, and, Approves, cancer, chemotherapy, Combination, Esophageal, expression, FDA, for, gastric, gastroesophageal, in, Junction, metastatic, of, Opdivo, or, Patients, PD-L1, regardless, status, with

PRINCETON, N.J.–(BUSINESS WIRE)– April 16, 2021 Opdivo is the first and only immunotherapy in combination with chemotherapy to deliver superior overall

Health News

Discrimination may increase risk of anxiety disorders regardless of genetics, study finds

01/15/2021 Anxiety, Discrimination, disorders, finds, Genetics, increase, may, of, regardless, risk, Study

Exposure to discrimination plays a significant role in the risk of developing anxiety and related disorders, even—in a first—after accounting

Health Problems

More intensive blood pressure therapy helps patients with type 2 diabetes regardless of cardiovascular risk

04/29/2019 2, blood, cardiovascular, Diabetes, helps, intensive, more, of, Patients, Pressure, regardless, risk, therapy, Type, with

People with type 2 diabetes who received intensive treatment to keep their blood pressure levels at 130/80 mm/Hg or below